Mirum Pharmaceuticals, Inc.
Nasdaq MIRM · Foster City, CA
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Infectious disease · Metabolic & endocrine · Neurology · Renal & urogenital · Women's health
Mirum Pharmaceuticals, Inc. is a clinical trial sponsor based in Foster City, CA, listed as Nasdaq MIRM. It has 12 active clinical trials with 1,557 planned participants, across 9 therapeutic areas. Since 2021 it has completed 14 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq MIRM
Fundraising
Pipeline · 12 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
5 approved drug applications with a product on the market.
Questions about Mirum Pharmaceuticals, Inc
Mirum Pharmaceuticals, Inc is lead sponsor of 12 active clinical trials on ClinicalTrials.gov, with 1,557 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 14 trials and stopped 1 early.
Mirum Pharmaceuticals, Inc is based in Foster City, CA and is listed as Nasdaq MIRM. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Mirum Pharmaceuticals, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-08.
Approve Suite is not affiliated with Mirum Pharmaceuticals, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.